This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Apr;63(4):534-5.

doi: 10.1111/j.1742-1241.2009.02024.x.

Sleight of hand in trial design: average behaviour is not average, not all new information is really new

PMID: 19335700
DOI: 10.1111/j.1742-1241.2009.02024.x

Editorial

Sleight of hand in trial design: average behaviour is not average, not all new information is really new

T Reynolds. Int J Clin Pract. 2009 Apr.

. 2009 Apr;63(4):534-5.

doi: 10.1111/j.1742-1241.2009.02024.x.

Author

PMID: 19335700
DOI: 10.1111/j.1742-1241.2009.02024.x

No abstract available

PubMed Disclaimer

Comment on

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M, Averna M, Missault L, Vaverkova H, Viigimaa M, Massaad R, Vandormael K, Johnson-Levonas AO, Brudi P. Farnier M, et al. Int J Clin Pract. 2009 Apr;63(4):547-59. doi: 10.1111/j.1742-1241.2009.02022.x. Epub 2009 Feb 16. Int J Clin Pract. 2009. PMID: 19222610 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information